The PHI Blog
PHI visit WFIRM – Inside the World of Regenerative Medicine
PHI headed to the Wake Forest Institute for Regenerative Medicine (WFIRM) in Winston-Salem to visit, collaborate and attend the World Stem Cell Summit 2023.
Learn more …
HoloMonitor M4FL in the spotlight at EACR and ISSCR 2023
Recapping the scientific conferences EACR and ISSCR 2023 that put HoloMonitor M4FL in the spotlight at its world premiere.
Learn more …
BIOSpektrum application article highlights HoloMonitor technology (in German)
PHI’s CSO, Kersti Alm, and Head of Communication, Lisa Bodily, have recently contributed to the June 2023 issue of the German BIOSpektrum journal. Their application article sheds light on how HoloMonitor’s technology is applied for non-invasive live cell analysis.
Learn more …
PHI is the most innovative MedTech Company in Scandinavia in 2023
We at PHI are humbled that the Global Health & Pharma Magazine has awarded us as the most innovative MedTech Company in Scandinavia in 2023!
Learn more …
Cytocentric measurement for regenerative medicine
PHI, together with our alliance for advancing cell-based biomanufacturing with Wake Forest Institute for Regenerative Medicine, BioSpherix, global analytics company SAS and others, has recently published a paper in Frontiers in Medical Technology about the critical cell and process parameters for cell and tissue products as well as technologies available in Regenerative Medicine. Here we highlighted more about the “what, why and how” of cyctocentric measurement.
Learn more …
CERN seminar: The Promise of Regenerative Medicine and AI
During this seminar, Peter Egelberg, Founder of PHI, will present the work carried out by PHI in the development of time-lapse cytometry instrumentation and software.
Learn more …